Newly Appointed Director of Cardiology at Loyola Medicine Can Discuss Can Discuss Angioplasties, Stents, Medications, Clinical Trials

Article ID: 675010

Released: 18-May-2017 2:05 PM EDT

Source Newsroom: Loyola University Health System

Expert Pitch
  • Credit: Loyola Medicine

    Verghese Mathew, MD

Verghese Mathew, MD, a nationally known interventional cardiologist, can discuss angioplasties, stents, medications, new devices, clinical trials, transcatheter aortic valve replacement and general cardiology topics. Dr. Mathew is director of cardiology at Loyola Medicine. Previously he had leadership roles at Mayo Cllinic.

Broadcast studio is available. 

Link to his bio:



Chat now!